A comprehensive roundup of the major stories from the region and the people involved and affected by them.
…
continue reading
Content provided by The ACRI Podcast and Australia-China Relations Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The ACRI Podcast and Australia-China Relations Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
30. Australian media discourse on China - with James Laurenceson
MP3•Episode home
Manage episode 231404614 series 2501497
Content provided by The ACRI Podcast and Australia-China Relations Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The ACRI Podcast and Australia-China Relations Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
When Australia talks about China, the China Opportunity and the China Challenge forms part of the discourse. The China Opportunity reflects the enormous economic benefits that Australia already derives from its $184 billion trade relationship with China. The China Challenge reflects the reality that as China has risen in wealth and power, some of its behaviour has conflicted with Australia’s interests. These narratives are grounded in facts and evidence. However, in the last 18 months the discourses of China Threat, China Angst and China Panic – which are less evidence-based – have become more prevalent. James Laurenceson, Deputy Director of the Australia-China Relations Institute (ACRI) at the University of Technology Sydney, joins host Bob Carr, Director of ACRI, to discuss the key findings of his new ACRI research report, ‘Do the claims stack up? Australia talks China’. The report examines recent Australian media discourse about China and assesses the evidence base for various claims made about China and Chinese influence and interference in Australia.
…
continue reading
46 episodes
MP3•Episode home
Manage episode 231404614 series 2501497
Content provided by The ACRI Podcast and Australia-China Relations Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The ACRI Podcast and Australia-China Relations Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
When Australia talks about China, the China Opportunity and the China Challenge forms part of the discourse. The China Opportunity reflects the enormous economic benefits that Australia already derives from its $184 billion trade relationship with China. The China Challenge reflects the reality that as China has risen in wealth and power, some of its behaviour has conflicted with Australia’s interests. These narratives are grounded in facts and evidence. However, in the last 18 months the discourses of China Threat, China Angst and China Panic – which are less evidence-based – have become more prevalent. James Laurenceson, Deputy Director of the Australia-China Relations Institute (ACRI) at the University of Technology Sydney, joins host Bob Carr, Director of ACRI, to discuss the key findings of his new ACRI research report, ‘Do the claims stack up? Australia talks China’. The report examines recent Australian media discourse about China and assesses the evidence base for various claims made about China and Chinese influence and interference in Australia.
…
continue reading
46 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.